title: 3-Methylindole is mutagenic and a possible pulmonary carcinogen.
abstract: Previous work has shown that bioactivation of the cigarette smoke pneumotoxicant 3-methylindole (3MI) by pulmonary cytochrome P450 enzymes is directly associated with formation of DNA adducts. Here, we present evidence that normal human lung epithelial cells, exposed to low micromolar concentrations of 3MI, showed extensive DNA damage, as measured by the comet assay, with similar potency to the prototypical genotoxic agents, doxorubicin and irinotecan. The DNA damage caused by 3MI was predominantly caused by single-strand breaks. Furthermore, we show that this damage decreased with time, given a subtoxic concentration, with detectable DNA fragmentation peaking 4 h after exposure and diminishing to untreated levels within 24 h. Pretreatment with an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1), NU1025, nearly doubled the DNA damage produced by 5 microM 3MI, implying that PARP1, which among other activities, functions to repair single-strand breaks in DNA, repaired at least some of the 3MI-induced DNA fragmentation. A key cellular response to DNA damage, phosphorylation, and nuclear localization of p53 was seen at subtoxic levels of 3MI exposure. 3MI was highly mutagenic, with essentially the same potency as the prototype carcinogen, benzo[a]pyrene, only when a lung-expressed CYP2F3 enzyme was used to dehydrogenate 3MI to its putative DNA-alkylating intermediate. Conversely, a rat liver S9 metabolic system did not bioactivate 3MI to its mutagenic intermediate(s). Concentrations higher than 25 microM caused apoptosis, which became extensive at 100 microM, similar to the response seen with 10 microM doxorubicin. Our findings indicate that there is a low concentration window in which 3MI can cause extensive DNA damage and mutation, without triggering apoptotic defenses, reinforcing the hypothesis that inhaled 3MI from cigarette smoke may be a potent lung-selective carcinogen.
authors.affiliation: Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah 84112, USA.
authors.forename: Jessica M
authors.initials: JM
authors.lastname: Weems
authors.forename: Ned S
authors.initials: NS
authors.lastname: Cutler
authors.forename: Chad
authors.initials: C
authors.lastname: Moore
authors.forename: William K
authors.initials: WK
authors.lastname: Nichols
authors.forename: David
authors.initials: D
authors.lastname: Martin
authors.forename: Evan
authors.initials: E
authors.lastname: Makin
authors.forename: John G
authors.initials: JG
authors.lastname: Lamb
authors.forename: Garold S
authors.initials: GS
authors.lastname: Yost
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D015153:Blotting, Western; D001980:Bronchi / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D002273:Carcinogens / Q000633:toxicity*; D002478:Cells, Cultured; D004249:DNA Damage; D004260:DNA Repair; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000139:chemically induced*; D009152:Mutagenicity Tests; D009153:Mutagens / Q000633:toxicity*; D012486:Salmonella typhimurium / Q000235:genetics; D012862:Skatole / Q000633:toxicity*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
chemical_list: D002273:Carcinogens; D009153:Mutagens; D016159:Tumor Suppressor Protein p53; D012862:Skatole
references.citation: Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13777-82
references.pmid: 10570149
references.citation: J Biol Chem. 1999 Feb 5;274(6):3642-50
references.pmid: 9920913
references.citation: Mol Cancer Res. 2007 Nov;5(11):1201-11
references.pmid: 18025263
references.citation: Mutat Res. 2001 Dec 12;484(1-2):3-18
references.pmid: 11733068
references.citation: Cancer Res. 1994 Mar 1;54(5):1169-74
references.pmid: 8118801
references.citation: Int J Cancer. 2000 Apr 20;90(2):59-67
references.pmid: 10814955
references.citation: Int J Cancer. 2004 Oct 10;111(6):813-8
references.pmid: 15300792
references.citation: Chem Res Toxicol. 1996 Jan-Feb;9(1):291-7
references.pmid: 8924606
references.citation: Science. 1991 Jun 21;252(5013):1708-11
references.pmid: 2047879
references.citation: Radiat Res. 2005 Aug;164(2):194-201
references.pmid: 16038590
references.citation: Toxicol Appl Pharmacol. 1993 Oct;122(2):182-90
references.pmid: 8212000
references.citation: Mutagenesis. 2004 May;19(3):169-85
references.pmid: 15123782
references.citation: Ann N Y Acad Sci. 2004 Dec;1028:247-57
references.pmid: 15650250
references.citation: Chem Res Toxicol. 2001 Aug;14(8):1014-24
references.pmid: 11511175
references.citation: Biochemistry. 2008 Sep 16;47(37):9756-70
references.pmid: 18717595
references.citation: Am J Clin Nutr. 1979 Jan;32(1):173-8
references.pmid: 367144
references.citation: Mol Pharmacol. 2003 May;63(5):1137-47
references.pmid: 12695542
references.citation: Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7303-7
references.pmid: 9207086
references.citation: Radiat Res. 2005 Aug;164(2):180-93
references.pmid: 16038589
references.citation: J Lab Clin Med. 1964 Jul;64:125-32
references.pmid: 14192557
references.citation: Environ Mol Mutagen. 2002;40(1):1-17
references.pmid: 12211071
references.citation: Mutat Res. 1975 Dec;31(6):347-64
references.pmid: 768755
references.citation: Arch Biochem Biophys. 1998 Jan 15;349(2):329-40
references.pmid: 9448722
references.citation: J Biol Chem. 1990 Dec 15;265(35):21907-13
references.pmid: 2123876
references.citation: Drug Metab Dispos. 2009 Oct;37(10):2018-27
references.pmid: 19608696
references.citation: Drug Metab Dispos. 2008 Jan;36(1):155-62
references.pmid: 17962375
references.citation: Chem Res Toxicol. 1989 Sep-Oct;2(5):273-9
references.pmid: 2519817
references.citation: J Biol Chem. 2002 Jun 21;277(25):23028-36
references.pmid: 11948190
references.citation: Toxicol Sci. 2003 Feb;71(2):229-36
references.pmid: 12563108
references.citation: Drug Metab Dispos. 2001 Jul;29(7):950-3
references.pmid: 11408359
references.citation: Biochemistry (Mosc). 2007 Dec;72(13):1399-421
references.pmid: 18282133
references.citation: Chem Res Toxicol. 2007 Jan;20(1):140-8
references.pmid: 17226936
references.citation: Drug Metab Dispos. 1991 Sep-Oct;19(5):977-84
references.pmid: 1686246